Streetbeat News

Stock Prices

CMA

Comerica (NYSE:CMA) has been analyzed by 14 analysts, showing a range of sentiments from bullish to bearish. The average 12-month price target has increased by 7.17% to $58.86. Analysts have adjusted their ratings and price targets, reflecting their views on Comerica's market position and financial performance.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:02 pm

AAVEUSD

Aave's price has dropped by 6.91% in the last 24 hours to $164.69, despite a 16% gain over the past week. Trading volume increased by 26% and its circulating supply rose slightly. Aave's market cap is $2.46 billion, ranking it #42.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:01 pm

BA

Boeing is facing significant challenges in 2024, including union strikes, safety concerns, and competition from SpaceX. Over 30,000 Boeing employees are on strike, affecting operations and potentially benefiting SpaceX in future space contracts. Boeing's Starliner mission faced issues, leaving astronauts stranded, while SpaceX's Dragon capsule will bring them back. These setbacks may impact Boeing's ability to secure future contracts with NASA and other agencies.

Portfolio Pulse from Chris Katje

September 24, 2024 | 7:01 pm

CVS

CVS Health has seen significant options activity, with a majority of trades showing bullish sentiment. Analysts have mixed ratings, with price targets ranging from $62 to $68. The stock is currently trading at $57.89, with a slight increase in price.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:00 pm

RGA

Analysts have provided diverse evaluations for Reinsurance Group of America (NYSE:RGA) over the past three months, with a positive shift in average price targets. The company's financial performance shows strong revenue growth and profitability, but concerns about financial leverage remain.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:00 pm

PODD

Insulet (NASDAQ:PODD) has significantly outperformed the market over the past 15 years, with an average annual return of 22.61%. A $100 investment in Insulet 15 years ago would now be worth $2,138.90, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:00 pm

VRT

Vertiv Holdings (NYSE:VRT) has significantly outperformed the market over the past 5 years, with an annualized return of 57.01%. A $100 investment in VRT 5 years ago would now be worth $947.61, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:00 pm

CTVA

Analysts have mixed ratings for Corteva (NYSE:CTVA), with recent sentiment showing a slight bearish shift. The average 12-month price target has decreased by 3.14% to $61.75. Analysts from Morgan Stanley, JP Morgan, Wells Fargo, and Keybanc have adjusted their ratings and price targets, reflecting dynamic market conditions. Corteva, a leader in agricultural inputs, shows strong financial health with above-average revenue growth, net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 7:00 pm

SLV

Silver prices are rising in response to the Federal Reserve's recent decision to cut interest rates.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:52 pm

EXK

GATO

PAAS

Shares of silver companies are experiencing an uptick due to rising precious metals prices following the Federal Reserve's rate cut.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:52 pm